Home › Hoofd-halskanker › Illinois › Chicago
Hoofd-halskanker klinische studies in Chicago, IL
10 studies voor Hoofd-halskanker zoeken deelnemers op locaties in en rond Chicago (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RekruterenFase 2/3
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- University of Illinois Cancer Center, Chicago
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
RekruterenFase 2
- The University of Chicago, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruterenFase 1/2
- University of Chicago, Chicago
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RekruterenFase 2
- University of Chicago Comprehensive Cancer Center, Chicago
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RekruterenFase 1
- The University of Chicago, Chicago
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
RekruterenFase 2
- The University of Chicago, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
RekruterenFase 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Chicago
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
RekruterenFase 1/2
- University of Illinois at Chicago, Chicago
Hoofd-halskanker studies in andere steden
- Houston, TX30 studies
- Boston, MA22 studies
- New York City, NY21 studies
- Nashville, TN21 studies
- St. Louis, MO15 studies
- Dallas, TX12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- San Antonio, TX10 studies
- Baltimore, MD10 studies
- Washington, DC10 studies
- Durham, NC10 studies
Andere studies in Chicago
- Niet-kleincellige longkanker61 studies
- Borstkanker59 studies
- Kanker (alle vormen)51 studies
- Metastatische kanker45 studies
- Prostaatkanker45 studies
- Longkanker41 studies
- Obesitas41 studies
- Eierstokkanker36 studies
- Colorectale kanker34 studies
- Beroerte34 studies
- Hartfalen31 studies
- Overgewicht29 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.